Characteristics of patients potentially eligible for pharmacotherapy for weight loss in primary care practice in the United States
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Summary: Objective: To describe the characteristics of real‐world patients potentially eligible for adjunctive pharmacotherapy for weight loss. Methods: Patients from the GE Centricity electronic medical record database were selected if they had body mass index (BMI) ≥30 or ≥27 to <30 kg m−2 with ≥1 obesity‐associated comorbidity (hypertension, dyslipidemia, or type 2 diabetes) from 2002–2011; were aged ≥18 years and had ≥12 months of continuous enrollment before and after the date of first eligible BMI recorded (index date). Descriptive statistics and logistic regression were used for analysis. Results: Of the 1,835,541 patients with overweight or obesity included, comorbidities were common (hypertension [55.4%], dyslipidemia [36.1%] and type 2 diabetes [13.4%]). The percentage of patients who received pharmacotherapy for weight loss was 0.7% within 12 months after the index date. Patients who received pharmacotherapy had higher BMI (median, 33.6 vs. 31.3 kg m−2), were younger (median, 42 vs. 52 years), primarily women (84.3 vs. 58.2%), commercially insured (70.1 vs. 50.4%) and had more frequent use of antidepressants (30.8 vs. 14.1%) and non‐steroidal anti‐inflammatory drugs (21.7 vs. 12.0%) than those who did not at baseline (all P values < 0.0001). Conclusions: Few eligible patients received pharmacotherapy for weight loss. Patients who received pharmacotherapy tended to be heavier, younger, female, commercially insured, and used more antidepressants and non‐steroidal anti‐inflammatory drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735 · cited 2×
“Obesity is associated with an increased risk of a variety of diseases, including type 2 diabetes, dyslipidemia, hypertension, sleep apnea, osteoarthritis, cardiovascular disease and respiratory diseases (2), as well as several types of cancers (3).”
BackgroundMulticenter, placebo-controlled trial of lorcaserin for weight management.
Smith, S. R., Weissman, N. J., Anderson, C. M., Sanchez, M., Chuang, E., Stubbe, S., Bays, H., & Shanahan, W. R. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909809 · Cited by 911
Long-term Drug Treatment for Obesity: A Systematic and Clinical Review
Yanovski, S. Z., & Yanovski, J. A. (2014) · JAMA · doi:10.1001/jama.2013.281361 · Cited by 876
Obesity and Obstructive Sleep Apnea: Pathogenic Mechanisms and Therapeutic Approaches
Schwartz, A. R., Patil, S. P., Laffan, A. M., Polotsky, V., Schneider, H., & Smith, P. L. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-137mg · Cited by 730 · cited 2×
“Obesity is strongly associated with an increased prevalence of sleep apnea (25,26).”
BackgroundApovian, C. M., Aronne, L., Rubino, D., Still, C., Wyatt, H., Burns, C., Kim, D., Dunayevich, E., & for the COR‐II Study Group (2013) · Obesity · doi:10.1002/oby.20309 · Cited by 720
Schwartz, M. B., & Brownell, K. D. (2004) · Body Image · doi:10.1016/s1740-1445(03)00007-x · Cited by 637
The association between chronic pain and obesity
Okifuji, A., & Hare, B. (2015) · Journal of Pain Research · doi:10.2147/jpr.s55598 · Cited by 597 · cited 4×
“Obesity has been shown to be associated with an increased risk of chronic pain, including low back pain, joint pain, headaches, fibromyalgia, widespread pain, abdominal pain, pelvic pain and neuropathic pain (23).”
BackgroundInfluentialWadden, T. A., Foreyt, J. P., Foster, G. D., Hill, J. O., Klein, S., O'Neil, P. M., Perri, M. G., Pi‐Sunyer, F. X., Rock, C. L., Erickson, J. S., et al. (2011) · Obesity · doi:10.1038/oby.2010.147 · Cited by 558
A systematic review of variables associated with the relationship between obesity and depression.
Preiss, K., Brennan, L., & Clarke, D. (2013) · Obesity Reviews · doi:10.1111/obr.12052 · Cited by 285
Use of prescription antiobesity drugs in the United States.
Hampp, C., Kang, E. M., & Borders‐Hemphill, V. (2013) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1342 · Cited by 103 · cited 3×
“Obesity Science & Practice published by John Wiley & Sons Ltd, and long clinical experience compared with other weight-loss drugs (6,10).”
BackgroundResult
Cited by
Progress and challenges in anti-obesity pharmacotherapy
Bessesen, D. H., & Van Gaal, L. F. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30236-x · Cited by 347
Simon, R., & Lahiri, S. W. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0221 · Cited by 59
Pharmacotherapy for Obesity—Trends Using a Population Level National Database
Elangovan, A., Shah, R., & Smith, Z. L. (2021) · Obesity Surgery · doi:10.1007/s11695-020-04987-2 · Cited by 56
Petrin, C., Kahan, S., Turner, M., Gallagher, C., & Dietz, W. H. (2016) · Obesity Science & Practice · doi:10.1002/osp4.53 · Cited by 38
Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude
Squadrito, F., Rottura, M., Irrera, N., Minutoli, L., Bitto, A., Barbieri, M. A., Cicala, G., Mecchio, A., Pallio, G., Marino, S., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110320 · Cited by 22
Metadata
- Authors
- Zhang, S., Manne, S., Lin, J., & Yang, J.
- Venue
- Obesity Science & Practice
- Publisher
- Wiley
- Published
- 2016-05-26
- Volume
- 2
- Issue
- 2
- Pages
- 104-114
- ISSN
- 2055-2238 (ISSN-L)
- OpenAlex
- W2409887465
- Cited by
- 24
- References
- 11
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characteristics of patients potentially eligible for pharmacotherapy for weight loss in primary care practice in the United States. https://app.cochat.ai/papers/10.1002/osp4.46
- The paper
- Zhang, S., Manne, S., Lin, J., & Yang, J. (2016). Characteristics of patients potentially eligible for pharmacotherapy for weight loss in primary care practice in the United States. Obesity Science & Practice. https://doi.org/10.1002/osp4.46
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.